The Influence of Inhaled CorticoSteroids Adherence on Treatment Response to Mepolizumab in Severe Eosinophilic Asthma
NCT05241769 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2022-02-16
Summary
The study aim is to look at the effect of the regular use of inhaled corticosteroids on the response and received from mepolizumab treatment which you are receiving or had received before.
Conditions
- Asthma; Eosinophilic
Sponsors & Collaborators
-
University Hospital Birmingham
lead OTHER
Principal Investigators
-
Adel Mansur · UHB
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-01
- Primary Completion
- 2023-09-01
- Completion
- 2023-09-01
More Related Trials
-
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control
NCT02281318 ·Status: COMPLETED ·Phase: PHASE3
-
Changes in Gene Transcription and Immunophenotypes Following Mepolizumab Treatment for Asthma
NCT05002621 ·Status: COMPLETED
-
Effect of Mepolizumab on Decrease of Systemic Corticosteroids in Patients With Severe Eosinophilic Asthma
NCT03453021 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy of MEDI-528 on Late Asthmatic Response With Atopic Asthma
NCT00394654 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability and Effects of MEDI-563 in Adults With Asthma
NCT00659659 ·Status: COMPLETED ·Phase: PHASE1
-
Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients
NCT02555371 ·Status: COMPLETED ·Phase: PHASE3
-
Using the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma Exacerbations
NCT05417906 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
NCT01000506 ·Status: COMPLETED ·Phase: PHASE2
-
A Study on the Effect of Mepolizumab Therapy on Daily Physical Activity of Patients With Severe Eosinophilic Asthma
NCT03739320 ·Status: UNKNOWN
-
Effects of Anti-IL5 Biological Treatments on Blood IgE Levels in Severe Asthmatic Patients
NCT04181190 ·Status: COMPLETED
-
The Effect of Omalizumab on Airway Responsiveness to Adenosine in Patients With Poorly Controlled Asthma
NCT00133042 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Interleukin (IL)- 4R-alpha Inhibition on Respiratory Microbiome and Immunologic Correlates in Severe Asthma
NCT05036733 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Tolerability of the Administration of MEDI-528 When Administered in Multiple Doses to Adults With Mild Persistent Asthma
NCT00507130 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
NCT01582503 ·Status: COMPLETED ·Phase: PHASE2
-
MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects
NCT01691859 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils
NCT02501629 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma
NCT04520165 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Mepolizumab Autoinjector in Asthmatics
NCT03099096 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Determine Long-term Safety of Mepolizumab in Asthmatic Subjects
NCT01842607 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Salmeterol on Eosinophil (EOS) Function
NCT00214019 ·Status: COMPLETED ·Phase: NA
-
Effect of Anti-interleukin 5 (IL5) Therapy on Sputum Cells and Cytokines
NCT04412044 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma
NCT05748600 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Phase 2A Study to Evaluate the Safety and Effect on Exercise Challenge Testing of MEDI-528 in Adults With Asthma
NCT00590720 ·Status: TERMINATED ·Phase: PHASE2
-
Exploring Asthma Exacerbations in Mepolizumab Treated Patients
NCT03324230 ·Status: COMPLETED
-
Steroids In Eosinophil Negative Asthma
NCT02066298 ·Status: COMPLETED ·Phase: PHASE3